QualityStocksNewsBreaks Archives - Page 74 of 1578

MondayFeb 23, 2026 11:24 am

QualityStocksNewsBreaks – OptimumBank Holdings, Inc. (NYSE American: OPHC) Forms OptimumFunding To Launch HUD And FHA Lending Platform

OptimumBank Holdings (NYSE American: OPHC) announced the formation of OptimumFunding LLC, a wholly owned subsidiary established to support a new HUD and FHA lending initiative and expand the company’s commercial real estate capabilities. The new platform will offer bridge-to-HUD financing and FHA- and HUD-insured loan origination focused on skilled nursing, senior housing and multifamily properties, building on the company’s existing healthcare and real estate lending expertise. In connection with the launch, the board approved a dividend to the holding company, which authorized a capital investment into OptimumFunding to support initial operations, with management stating the initiative is designed to diversify revenue streams, enhance long-term profitability and provide borrowers with an…

MondayFeb 23, 2026 11:08 am

QualityStocksNewsBreaks – MedWell Ai, Inc. (OTCQB: MWAI) Reports 280% Quarterly Revenue Growth In Fiscal Q2 2025

MedWell Ai (OTCQB: MWAI) announced the filing of its Form 10-Q for the quarter ended Dec. 31, 2025, reporting revenue of $548,315 for the fiscal second quarter, up more than 280% from $142,861 in the prior-year period, and six-month revenue of $1,075,806, up more than 700% year-over-year. The company also reported reduced operating losses, lower general and administrative expenses and improved net loss per share for both the three- and six-month periods, alongside a reduction in liabilities to $468,655 from $805,500 as of June 30, 2025, reflecting progress in its AI-driven pharmaceutical, healthcare and wellness portfolio strategy. To view the full press…

MondayFeb 23, 2026 10:20 am

QualityStocksNewsBreaks – Ucore Rare Metals Inc. (TSXV: UCU) (OTCQX: UURAF) Highlights Rare Earth Price Surge And Ranks Second On 2026 TSX Venture 50

Ucore Rare Metals (TSXV: UCU) (OTCQX: UURAF) commented on recent sharp price increases and widening pricing disparities between China and ex-China markets for key heavy rare earth elements following China’s April 4, 2025 export controls, noting dysprosium oxide exceeding $200/kg in China and $1,000/kg outside China, and terbium oxide reaching $900/kg in China and more than $4,500/kg ex-China, alongside gains in praseodymium-neodymium oxide. The company said the pricing bifurcation underscores the importance of developing a secure North American midstream refining supply chain centered on its RapidSX(TM) technology and planned Louisiana Strategic Metals Complex, and further announced it ranked second overall…

MondayFeb 23, 2026 9:50 am

QualityStocksNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) And Wellgistics Health Inc. Expand Blockchain-Enabled Healthcare Partnership

Datavault AI (NASDAQ: DVLT) and Wellgistics Health Inc. (NASDAQ: WGRX) announced plans to expand their existing blockchain-enabled smart contracts partnership beyond prescription tracking to support Wellgistics’ emerging Healthcare as a Service model. The expanded collaboration will integrate additional Datavault AI intellectual property into Wellgistics’ EinsteinRx(TM) and PharmacyChain(TM) platforms to enable secure data integration from pharmacies, hospitals, clinics, diagnostic labs, telehealth providers, wearables and insurers, supporting a hub-and-spoke prescription delivery model and a comprehensive app-based patient engagement solution designed to improve outcomes while reducing total cost of care. To view the full press release, visit https://ibn.fm/V5E1p About Datavault AI Datavault AI(TM)…

MondayFeb 23, 2026 9:40 am

QualityStocksNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured In NetworkNewsAudio On Biotech M&A Trends

Oncotelic Therapeutics (OTCQB: OTLC) is featured in a NetworkNewsAudio Audio Press Release titled “Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A,” highlighting growing investor interest in clinical-stage platforms supported by existing human data. The editorial notes that programs demonstrating clinical activity offer clearer valuation benchmarks and reduced uncertainty compared with preclinical assets, positioning companies with diversified clinical pipelines, including oncology and CNS-focused targets such as TGF-β signaling and delivery-based approaches, to align with industry demand for validated mechanisms and strategic portfolio depth. To view the full press release, visit https://ibn.fm/cZmVn About Oncotelic Therapeutics Inc. Oncotelic Therapeutics…

MondayFeb 23, 2026 9:30 am

QualityStocksNewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Projects Over 500% Q1 Revenue Growth As Government Deployment Accelerates

Safe Pro Group (NASDAQ: SPAI) announced it expects first quarter 2026 revenue to increase more than 500% year-over-year, driven by initial deliveries under a recently awarded $1,000,000 U.S. Government subcontract supporting deployment of its AI-Powered Edge Processing platform. Based on preliminary, unaudited results, the company said the acceleration reflects its transition from development-stage operations into revenue-generating government programs, supported by low-rate initial production, a strengthened balance sheet following a $14 million PIPE financing in Q4 2025 led by Ondas Holdings Inc. (NASDAQ: ONDS) and Unusual Machines Inc. (NYSE American: UMAC), and commercialization of its patented Safe Pro Object Threat Detection…

MondayFeb 23, 2026 9:10 am

QualityStocksNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Updates Distribution Date For Warrant And Token Dividends

Datavault AI (NASDAQ: DVLT) announced that its board of directors has changed the distribution date for its previously declared dividend of warrants to purchase common stock and its dividend of Dream Bowl Meme Coin II tokens to Feb. 27, 2026, from Feb. 23, 2026, and Feb. 21, 2026, respectively, while the record date remains Jan. 7, 2026. The board retains discretion to further change or revoke the distributions prior to the distribution date, and the company intends to file a prospectus supplement to its Form S-3 shelf registration statement with the SEC registering the warrant distribution and the shares issuable…

MondayFeb 23, 2026 9:00 am

QualityStocksNewsBreaks – Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) Announces Key Management Appointments At Ambler Metals Joint Venture

This article has been disseminated on behalf of Trilogy Metals Inc. and may include paid advertising. Trilogy Metals (NYSE American: TMQ) (TSX: TMQ) announced senior management appointments at its 50/50 joint venture with South32 Limited, Ambler Metals LLC, which is advancing the Upper Kobuk Mineral Projects in Alaska’s Ambler Mining District. Michael Galicki has been named Vice President, Exploration; Cole Schaeffer Vice President, Human Resources, Community and Partnerships; Jenna Tan Vice President, Finance; and Ron Rimelman Senior Director, Permitting. The appointments strengthen Ambler Metals’ technical, financial and permitting leadership as it advances exploration drilling, community engagement, feasibility planning and expedited…

FridayFeb 20, 2026 3:03 pm

QualityStocksNewsBreaks – Mangoceuticals, Inc. (NASDAQ: MGRX) Reports 336% Sales Growth for $99 Monthly TRT Program

Mangoceuticals (NASDAQ: MGRX) operating under the MangoRx and PeachesRx brands, announced initial success for its newly launched all-inclusive injectable testosterone replacement therapy program priced at $99 per month, which includes doctor visits, consultations, lab work and prescribed medication. Since launching in mid-December, month-over-month sales of the injectable TRT program have increased 336% while customer acquisition costs declined 54%, reflecting what the company described as growing demand for convenient hormone health solutions delivered through its telehealth platform. MangoRx expects TRT to serve as a primary growth driver, alongside oral formulations including PRIME by MangoRx powered by Kyzatrex, as it seeks to expand its presence in the global TRT market, estimated at approximately $2.1 billion to $2.2 billion in 2025.…

FridayFeb 20, 2026 11:27 am

QualityStocksNewsBreaks – ParaZero Technologies Ltd. (NASDAQ: PRZO) Secures Additional Israeli Defense Order for DefendAir Counter-UAS System

ParaZero Technologies (NASDAQ: PRZO), an aerospace defense company focused on autonomous solutions for manned and unmanned aerial systems, announced it has received an additional order from a second branch of an Israeli defense entity for its DefendAir(TM) multi-layered counter-UAS solution. The order follows an earlier successful deployment and includes specialized high-precision net launchers for urban and field use, interception pods compatible with handheld, stationary and drone-mounted configurations, and a comprehensive training package featuring simulation-based and live-fire modules. The company said recent demonstrations achieved 100% interception rates against high-speed threats, including FPV drones and heavy-lift platforms, highlighting DefendAir’s non-explosive, patent-protected net-based interception technology as a cost-effective alternative to traditional counter-drone systems. To…

Site Search

Company Search

Category: QualityStocksNewsBreaks